Loading

Annals of Pediatrics and Child Health

Impact of Evidence-Based Psychosocial Treatment on Service Utilization Among Adolescents with Co-Occurring Posttraumatic Stress Disorder Symptoms and Substance Use Problems

Research Article | Open Access | Volume 11 | Issue 4

  • 1. Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, USA
  • 2. Department of Psychiatry, Indiana University School of Medicine, USA
+ Show More - Show Less
Corresponding Authors
Austin Hahn, Department of Psychiatry, Medical University of South Carolina, Charleston, SC 29425, USA
Abstract

Objective: To examine the impact of evidence-based, trauma-focused treatment on mental health service utilization and juvenile justice involvement among adolescents with co-occurring posttraumctic stress disorder (PTSD) symptoms and substance use problems.

Method: This study is a secondary analysis of a randomized controlled trial examining the efficacy of Risk Reduction Through Family Therapy (RRFT), an integrated treatment for youth with co-occurring PTSD and substance use problems. Participants were 127 adolescents (aged 13-18 years) with at least one memorable experience of interpersonal trauma, at least one day of nontobacco substance use in the previous 90 days, and five or more PTSD symptoms. Adolescents (87% female; mean [SD] age 15.4 [1.3]; 63% white) were randomized to RRFT (n = 61) or treatment as usual (TAU; primarily Trauma Focused Cognitive Behavioral Therapy [TF-CBT]; n = 63) groups. Data on health service utilization was collected at baseline (pre-treatment) and at 18 months posttreatment using the Services Assessment for Child and Adolescent (SACA).

Results: Youth in both treatment conditions had fewer inpatient mental health hospitalizations and lower rates of juvenile justice involvement at 18-month follow up. Participants who received RRFT showed a relatively greater reduction in hospitalizations post-treatment compared with those who received TAU.

Conclusions: Evidence-based trauma-focused treatment, irrespective of the incorporation of specific substance use modalities, can be effective in reducing utilization of costly and intensive health services among youth with PTSD. These findings suggest that evidence-based trauma-focused psychosocial treatment has the potential to offset the public health costs associated with the comprehensive treatment needs of this population.

Keywords

Traumatic Stress,  Service Utilization,  Adolescents

CITATION

Goodyear M, Hahn1 AM, Adams ZW, Danielson CK (2023) Impact of Evidence-Based Psychosocial Treatment on Service Utilization Among Adolescents with Co-Occurring Posttraumatic Stress Disorder Symptoms and Substance Use Problems. Ann Pediatr Child Health 2023; 11(4): 1312.

INTRODUCTION

Childhood trauma exposure is widely prevalent, with more than 65% of youth experiencing at least one traumatic event before they reach adulthood [1,2].Traumatic events are defined by the DSM-V as actual or threatened death, serious injury, or sexual violence and may include experiences such as interpersonal victimization (e.g., physical, sexual, and/or emotional abuse, racism-related trauma), sudden or violent loss of a loved one, serious accidents or injuries, and natural disasters. Youth who have been exposed to trauma are at elevated risk for mental health disorders, including posttraumatic stress disorder (PTSD) and substance use disorders [3-5].These youth are also higher utilizers of resource-intensive elements of comprehensive  treatment for youth with co-occurring psychiatric problems, such as inpatient mental health treatment and state systems of care (e.g., juvenile justice, foster care) [6,7].

Existing evidence-based psychosocial treatments, including Trauma-Focused Cognitive Behavioral Therapy (TF-CBT), have been established as effective and widely-used treatments designed to reduce traumatic stress in youth with PTSD and have been shown to reduce utilization of high-end mental health services (i.e., inpatient hospitalization, intensive outpatient programs) [8]. However, few treatments for adolescent PTSD incorporate treatment for substance use problems, which occur at a high rate among youth with PTSD. Adolescents with co-occurring PTSD and substance use problems also use health services at higher rates than those with PTSD or substance use problems in isolation, thus, supporting the need for integrated treatment— and for further research into studying the impact of integrated treatment into utilization of resource-intensive services for this population. Furthermore, recent recommendations indicate that substance use risk reduction should be implemented as a secondary prevention strategy among at-risk youth (e.g., youth with PTSD), even if not yet experiencing substance use problems [9]. One recent treatment integrated approach, Risk Reduction Through Family Therapy (RRFT), has incorporated substance use components to allow for concomitant treatment of PTSD and substance use problems, and has found robust effects in reducing both PTSD and substance use related symptoms [10].

Despite increasing rates of adolescent substance use problems (e.g., opioid overdose) [11], and mental health problems and robust empirical evidence for trauma-focused treatment, widespread adoption of evidence-based treatment models is lacking due to the costs associated with implementing and maintaining an evidence-based treatment model [12,13]. Considering the economic burden of childhood traumatic stress, which has been estimated at $428 billion per year, the implementation of integrated evidence-based treatments for PTSD and substance use problems has the potential to offset public health costs by reducing future need for resource intensive mental health services [14].

This study examined the impact of evidence-based, traumafocused treatment for adolescents with co-occurring PTSD symptoms and substance use problems on costly services often required for this population. Specifically, we examined the effect of trauma-focused treatment on in-patient hospitalizations for mental health or substance use problems and juvenile detention outcomes. We also examined these outcomes independently among adolescents receiving evidence-based treatment targeting both PTSD and substance use (i.e., RRFT) and those receiving trauma-focused treatment for PTSD only (i.e., TF-CBT).

METHOD

Participants

The current study is secondary analysis of a randomized controlled trial examining the efficacy of Risk Reduction Through Family Therapy (RRFT), an integrated treatment for youth with co-occurring PTSD symptoms and substance use problems [10]. Participants were 127 youth recruited from childhood advocacy centers in the southeast United States that provide mental health services to youth who have experienced child maltreatment. Inclusion criteria were: adolescents aged 13-18 years who reported at least one memorable experience of interpersonal trauma, at least one day of nontobacco substance use in the previous 90 days, and five or more PTSD symptoms. Youth with pervasive developmental disability, intellectual disability, active suicidal or homicidal ideation, or active psychosis, or those already engaged in treatment were excluded. A total of 127 adolescents were enrolled in the RCT and randomized to RRFT (n = 61) or treatment as usual (TAU; TF-CBT; n = 63) groups. Approximately 87% of youth in the sample were female. The mean age was 15.4 (SD = 1.3). Ethnic/racial breakdown was as follows: white (63%), black (29%) Latino/a/x (5.6%), and biracial (2%). Five percent of the sample was Hispanic. Participants reported experiencing a mean of 3.6 (SD = 2.0) different traumatic event types. Treatment fidelity was closely monitored through gold-standard measures. Detailed description of the study protocol is published elsewhere [15].

Measures

Demographics: Participants were asked to provide information about age, sex, ethnicity, Hollingshead socioeconomic data [16], and family composition.

Service Utilization:The Services Assessment for Child and Adolescent (SACA), a widely used measure of youth service utilization, assessed participants’ use of mental health services, including outpatient services, inpatient/residential services, and school services. Service utilization was assessed at baseline (lifetime use, use in the past six months) and at an 18 month postbaseline follow-up assessment (use in the past six months). The SACA has demonstrated strong validity and reliability among adolescents and caregivers.17.

RESULTS

All data analyses were conducted using STATA 17 (StataCorp, 2021). Adolescents in both treatment conditions demonstrated a significant decrease in substance use and/or mental health hospitalizations from baseline to 18-month follow-up (t(194) = 2.63, p = .009). Overall, youth who received either type of evidence-based trauma-informed treatment offered in the study had fewer inpatient hospitalizations and lower rates of juvenile justice involvement. In general, youth who received RRFT demonstrated slightly lower use of mental health services compared to youth who received TAU. See Table 1 for service utilization at baseline and 18-month follow-up among the full sample, RRFT group, and control group.

Table 1: Service Utilization at Baseline and 18-months Following Evidence-Based Treatment for Co-Occurring PTSD and Substance Use

  Baseline 18-months
  Full Sample RRFT TAU Full Sample RRFT TAU
N = 127 n = 65 n = 62 N = 69 n = 34 n = 35
Any Hospitalizations (Mental Health or Substance Use) 30.70% 30.80% 30.70%      
Any Hospitalization past six months 17.30% 18.50% 16.10% 4.30% 0.0%* 8.60%
Mental Health Hospitalizations lifetime 26.80% 26.20% 27.40%      
Mental Health Hospitalizations past six months 13.40% 12.30% 14.50% 4.70% 0.0%* 9.40%
Substance Use Hospitalizations Lifetime 7.90% 9.20% 6.50%      
Substance Use Hospitalizations past six months 5.50% 7.70% 3.20% 1.40% 0.00% 2.90%
Stays in detention center or R&E lifetime 11.00% 12.30% 9.70%      
Stays in detention center or R&E past six months 7.10% 9.20% 4.80% 5.80% 2.90% 8.60%
Juvenile prison/correctional facility lifetime 7.10% 7.70% 6.50%      
Juvenile prison/correctional facility past six months 5.50% 6.20% 4.80% 4.40% 5.90% 2.90%

Note. RRFT: Risk-Reduction Through Family Therapy. R&E: Reception & Evaluation. Number of observations differ due to missing data. * p < .01 between RRFT and TAU.

 

DISCUSSION

This study examined the impact of evidence-based trauma treatment on service utilization in adolescents with co-ocurring PTSD symptoms and substance use problems. Youth in both treatment groups benefitted in terms of reduction of costly resource use across these areas from pre- to post- treatment (through 18 months post-baseline follow up). Adolescents who received RRFT showed a relatively greater reduction in hospitalizations post-treatment compared with those who received TAU. In regard to juvenile justice involvement, youth receiving either evidence-based trauma treatment showed slight reductions in utilization, although there was no significant difference between treatment groups.

These findings demonstrate that engagement in traumafocused treatment, regardless of the incorporation of specific substance use modalities, can be effective in reducing hospitalizations among teens. However, for adolescents with co-occurring PTSD and substance use problems, integrated treatment targeting both symptom groups may result in the strongest reduction in hospitalizations following intervention. The reduction in rates of hospitalization could be due to a number of factors. Naturally, the reduction of substance use and PTSD symptoms would decrease overall mental health symptom severity, leading to lower rates of hospitalization. Symptom reduction may also increase adolescents’ engagement in greater prosocial and healthy activities (which are targeted elements of RRFT treatment), thus further reducing the likelihood of requiring hospitalization post-treatment.

Overall, the results of this study indicate a potential for great public health cost savings in the application of evidencebased trauma-focused treatment for youth with co-occurring PTSD and substance use problems. The rate of mental health hospitalizations in youth increased by 25% between 2009 and 2019 and cost $1.37 billion [18]. This increase has been further exacerbated by the pandemic and National State of Emergency for Child and Aoldescent Mental Health [19]. For youth with cooccurring PTSD and substance use problems, who often utilize more intensive (and expensive) health services at higher rates than those with PTSD only, these costs may be offset by the implementation of integrated treatment strategies.12 Thus, the additional costs associated with integrated treatments (e.g., RRFT incorporates clinician-to-adolescent and -to-caregiver text messaging in between sessions to increase likelihood of daily uptake of skills and strategies taught in session) are likely to ultimately serve as worthy investments to prevent the more expensive costs that extend from resource-intensive servives (e.g., psychiatric in-patient hospitalizations). A current, large scale clinical trial is under-way to examine the cost-effectiveness of RRFT.

Despite these findings, several limitations should be noted. First, due to the interval between baseline and final follow-up assessment (i.e., 18 months), a portion of participants were lost to follow-up. Of participants who completed the SACA at baseline, 54.3% completed the SACA at 18-months post-baseline follow up. Another limitation is that the majority of the sample was female (87.1%). Adolescent males who develop PTSD following trauma exposure may be at higher risk for development of substance use problems than adolescent females, thus, replication with a larger representation of male participants is needed. Future research should continue to investigate the effects of evidence-based trauma treatment, as well as integrated treatment for PTSD and substance use problems, on utilization of mental health services and associated public health costs. Such research is critical to identify the most efficacious and cost-effective approaches to improving long-term behavioral health trajectories for young people who have experienced trauma, which will ultimately have a positive impact on public health at the population level as well.

ACKNOWLEDGEMENT

This research and manuscript preparation was supported in part by grants from the National Institute on Drug Abuse (R01DA031285; K24DA039783; PI: Danielson; 1R01DA03288; MPI: Danielson, Riggs; K23DA050800, PI: Hahn) and the National Institute on Mental Health (T32MH018869, MPI: Danielson, Kilpatrick).

REFERENCES

1. McLaughlin KA, Koenen KC, Hill ED, Petukhova M, Sampson NA, Zaslavsky AM, et al. Trauma exposure and posttraumatic stress disorder in a national sample of adolescents. J Am Acad Child Adolesc Psychiatr. 2013; 52: 815-830.e814.

2. Alisic E, Zalta AK, van Wesel F, Larsen SE, Hafstad GS, Hassanpour K, et al. Rates of post-traumatic stress disorder in trauma-exposed children and adolescents: meta-analysis. Br J Psychiatry. 2014; 204: 335-340.

3. Blumenthal H, Blanchard L, Feldner MT, Babson KA, Leen-Feldner EW, Dixon L. Traumatic event exposure, posttraumatic stress, and substance use among youth: A critical review of the empirical literature. Current Psychiatry Reviews. 2008; 4: 228-254.

4. Macdonald A, Danielson CK, Resnick HS, Saunders BE, Kilpatrick DG. PTSD and comorbid disorders in a representative sample of adolescents: The risk associated with multiple exposures to potentially traumatic events. Child Abuse Negl. 2010; 34: 773-783.

5. Elizabeth TC. Lippard, Charles B. Nemeroff. The Devastating Clinical Consequences of Child Abuse and Neglect: Increased Disease Vulnerability and Poor Treatment Response in Mood Disorders. American J Psychiatry. 2020; 177: 20-36.

6. Goger P, Zerr AA, Weersing VR, Dickerson JF, Crawford PM, Sterling SA, et al. Health Service Utilization among Children and Adolescents with Posttraumatic Stress Disorder: A Case-Control Study. J Dev Behav Pediatr. 2022; 43: 283-290.

7. Choi KR, Briggs EC, Seng JS, Graham-Bermann SA, Munro-Kramer ML, Ford JD. Service usage typologies in a clinical sample of trauma exposed adolescents: A latent class analysis. Psychol Trauma. 2018; 10: 652-661.

8. Greer D, Grasso DJ, Cohen A, Webb C. Trauma-focused treatment in a state system of care: is it worth the cost? Adm Policy Ment Health. 2014; 41: 317-323.

9. Danielson CK, McCauley JL, Hinkley J, Hahn A, Moreland A, Lopez C, et al. Prevention and Intervention with Young People as a Critical Public Health Strategy to Curtail the Opioid Epidemic: A Call to Action. J Addict Res Ther. 2023; 14: 521.

10. Danielson CK, Adams Z, McCart MR, Chapman JE, Sheidow AJ, Walker J, et al. Safety and Efficacy of Exposure-Based Risk Reduction Through Family Therapy for Co-occurring Substance Use Problems and Posttraumatic Stress Disorder Symptoms Among Adolescents: A Randomized Clinical Trial. JAMA Psychiatry. 2020; 77: 574-586.

11. Friedman J, Godvin M, Shover CL. Trends in drug overdose deaths among US adolescents, January 2010 to June 2021. JAMA. 2022; 327: 1398-1400.

12. Suarez LM, Belcher HM, Briggs EC, Titus JC. Supporting the need for an integrated system of care for youth with co-occurring traumatic stress and substance abuse problems. Am J Community Psychol. 2012; 49: 430-440.

13. McLellan AT, Meyers K. Contemporary addiction treatment: a review of systems problems for adults and adolescents. Biol Psychiatry. 2004; 56: 764-770.

14. Peterson C, Florence C, Klevens J. The economic burden of child maltreatment in the United States, 2015. Child Abuse Negl. 2018; 86: 178-183.

15. Hahn AM, Adams ZW, Chapman J, McCart MR, Sheidow AJ, de Arellano MA, et al. Risk reduction through family therapy (RRFT): Protocol of a randomized controlled efficacy trial of an integrative treatment for co-occurring substance use problems and posttraumatic stress disorder symptoms in adolescents who have experienced interpersonal violence and other traumatic events. Contemp Clin Trials. 2020; 93: 106012.

16. Hollingshead A. Four Factor Index of Social Status. In. New Haven, CT: Yale University; 1975.

17. Horwitz SM, Hoagwood K, Stiffman AR, Summerfeld T, Weisz JR, Costello EJ, et al. Reliability of the services assessment for children and adolescents. Psychiatr Serv. 2001; 52: 1088-1094.

18. Arakelyan M, Freyleue S, Avula D, McLaren JL, O’Malley AJ, Leyenaar JK. Pediatric Mental Health Hospitalizations at Acute Care Hospitals in the US, 2009-2019. JAMA. 2023; 329: 1000-1011.

19. AAP-AACAP-CHA Declaration of a national emergency in child and adolescent mental health [press release]. 2021.

Goodyear M, Hahn1 AM, Adams ZW, Danielson CK (2023) Impact of Evidence-Based Psychosocial Treatment on Service Utilization Among Adolescents with Co-Occurring Posttraumatic Stress Disorder Symptoms and Substance Use Problems. Ann Pediatr Child Health 2023; 11(4): 1312.

Received : 06 Jul 2023
Accepted : 13 Aug 2023
Published : 19 Aug 2023
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X